NIC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NIC is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows stable-to-neutral technicals and supportive analyst sentiment, but there is no AI Stock Picker or SwingMax buy signal, no recent news catalyst, and financials are unavailable in the provided data. At a pre-market price of 140.5, the setup looks more like a reasonable hold/watch than an immediate buy, especially for an impatient investor seeking a clear entry.
Technical picture is mixed and mostly neutral. MACD histogram is positive at 0.0745 but contracting, which suggests momentum is fading rather than accelerating. RSI_6 at 43.593 is neutral-to-weak, not an oversold buy signal. Moving averages are converging, pointing to a sideways consolidation phase. Price is slightly below the pivot at 141.189, with near-term resistance at 144.944 and support at 137.434. Overall trend is not bearish, but it is not strong enough to justify an aggressive entry.
["Piper Sandler maintained an Overweight rating and sees Nicolet as well-positioned for superior TBV growth.", "Analyst expects top-tier profitability and a return to high-quality C&I-oriented organic balance sheet growth later this year.", "Options market sentiment is bullish with a very low put-call ratio.", "No recent negative news in the past week.", "Similar candlestick-pattern analysis suggests a positive one-month return profile."]
["No news catalysts in the recent week, so there is no fresh event-driven upside trigger.", "MACD momentum is positive but contracting, which weakens near-term trend strength.", "RSI is neutral, not signaling a strong entry point.", "Hedge funds and insiders are both neutral with no notable recent buying.", "No congress trading activity was reported.", "Financial snapshot data is unavailable, limiting conviction on current fundamental growth."]
Latest quarter financial details were not provided because the financial snapshot returned an error. As a result, there is no reliable quarterly revenue, EPS, or deposit/loan growth data to assess. The only available fundamental clue is analyst commentary pointing to strong TBV growth and future C&I-led organic balance sheet growth.
Recent analyst trend remains constructive. On 2026-04-22, Piper Sandler lowered the price target slightly to $183 from $185 but kept an Overweight rating, citing noisy Q1 results while still expecting strong TBV growth and high profitability. Wall Street pros appear positive overall on the long-term story, but the lowered target reflects some near-term caution. There are no competing analyst updates in the provided data.
